# Sermorelin vs CJC-1295: Native GHRH(1-29) and a Long-Acting GHRH Analogue

> Sermorelin vs CJC-1295: both are GHRH analogues on the same receptor, but native sermorelin clears in minutes while CJC-1295 uses a Drug Affinity Complex to extend stimulation for days.

Same receptor, very different clock. Native sermorelin clears in ~10-12 minutes; CJC-1295 binds albumin via a Drug Affinity Complex to stretch stimulation across days. The half-life fork, read straight.

## The short version

Sermorelin vs CJC-1295 is the same molecule family on a different timer. Both are GHRH analogues — both copy the brain's "make growth hormone" signal and push the same pituitary receptor. The difference is how long each lasts. Native sermorelin (GHRH(1-29)) is cleared from the blood in about ten minutes. CJC-1295 was engineered to stick around: it carries a chemical clip (a Drug Affinity Complex, or DAC) that latches onto a blood protein, stretching the signal from minutes to days. That timing difference is the whole comparison.

## Same receptor, different half-life

Sermorelin vs CJC-1295 starts from a shared mechanism: both are GHRH analogues that act on the same pituitary GHRH receptor to release the body's own GH [15]. Where they part is pharmacokinetics. Native sermorelin (GHRH(1-29)) is short-acting — a plasma half-life on the order of ~10-12 minutes, with rapid elimination, even though a single dose keeps serum GH elevated for roughly 3 hours [3].

That brevity is the engineering problem CJC-1295 was built to solve. CJC-1295 uses a Drug Affinity Complex (DAC) — a maleimide group that binds serum albumin — to dramatically extend the peptide's residence and prolong stimulation of GH and IGF-1 for days in healthy adults [15]. The structural basis of the long-acting GHRH analogues (the D-Ala2 substitution and the DAC) is exactly what the native fragment lacks [15].

## What the duration difference means for the research

A short pulse and a multi-day plateau produce different research questions. Native GHRH(1-29) was studied as repeated short stimuli — once daily in children, twice daily in older men — so each dose is a discrete pulse layered onto the body's own pulsatile rhythm [1][2]. A DAC-extended analogue, by contrast, raises the baseline of stimulation for days, a different pharmacology with its own implications for feedback and tolerability.

The shared limit is human data. Long-term adult safety and efficacy data are limited across this analogue family, and authorities caution that secretagogue use for the effects of aging is not yet established [5]. Because GH and IGF-1 are mitogenic, chronically elevating them carries a recognized theoretical oncologic concern for any member of the class [15].

## Reading the comparison honestly

The duration contrast is real, but it is not a verdict on which peptide is "better" — the literature does not frame it that way, and neither does this digest. Native sermorelin's short action is the feature that preserves a pulsatile, feedback-regulated release pattern [4]; CJC-1295's extended action is a different design with different trade-offs [15].

For the receptor-level mechanism shared by both, see [how sermorelin works at the GHRH receptor](/research); for the contrasting GHRP mechanism, see [sermorelin vs ipamorelin](/sermorelin-vs-ipamorelin). Nothing here is a dosing instruction — it is a pharmacokinetic comparison drawn from the published record.

## How does sermorelin compare to CJC-1295?

Both are GHRH analogues that act on the same pituitary GHRH receptor, but native sermorelin (GHRH(1-29)) is short-acting — a plasma half-life of roughly 10-12 minutes [3] — whereas CJC-1295 uses a Drug Affinity Complex to bind albumin and prolong stimulation of GH and IGF-1 for days in healthy adults [15]. Same receptor, very different duration of action.

---

A green-phosphor terminal reading of the sermorelin record — each GHRH(1-29) figure logged to its study, the ~10-12-minute half-life that motivates the longer-acting analogues surfaced first, the formerly-approved-now-compounded history stated as filed, and the body-composition evidence marked as tesamorelin where it belongs; the 'order' here is a command at a prompt, never a checkout, and nothing on this console is dosed, dispensed, or sold.